Eris Lifesciences has informed that an allotment of 33,287 equity shares has been made on March 06, 2025, pursuant to exercise of options under the ESOP Scheme. The paid-up share capital of the Company accordingly stands increased from Rs 13,61,29,282 (13,61,29,282 equity shares of Re 1 each) to Rs. 13,61,62,569 (13,61,62,569 equity shares of Re 1 each).
The above information is a part of company’s filings submitted to BSE.